News & Articles

Update offers new functionality to enhance workflows in biologics discovery and cell line development

SelectScience speaks to the President of the German Society for Mass Spectrometry, who is using chemical cross-linking and mass spectrometry to provide deeper proteomics insights

Label-free, 3D holotomography imaging enables researchers to observe morphological and chemical alterations of host cells without transfection or dye staining

Movement bans are often used to control outbreaks of infectious diseases such as bovine tuberculosis (bTB) in livestock

The sophisticated software, that can resolve complex, mixed DNA profiles, will be used as a component of student coursework

The Barostim Neo System was given a Breakthrough Device designation by the FDA

SP Scientific and Lab-i-DOSiTECNO sign global partnership agreement

Fujitsu technology utilizes mathematical models that incorporate rainfall and water level data for more precise predictions

In this popular on-demand webinar, learn more about which applications may benefit from a particular pump and how to select an LC system based on your application needs

Learn about Olympus’ new solution for 3D high-content analysis and how patient-derived organoids can be utilized for more effective drug candidate profiling

Dr. John Connolly, CSO of Tessa Therapeutics, reveals how a new approach to cell-based therapy in cancer could circumvent severe immunotherapy side effects and effectively target aggressive solid tumors

Learn about the development of a new Zika vaccine at the Instituto Butantan and key technology for maintaining consistency in immunobiological product production

The U.S. Food and Drug Administration has approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis

Roche's assay to be used to find patients eligible for treatment with Tecentriq in combination with Abraxane

Long, high-yield oligos with low error rate enable researchers to skip amplification steps and start projects immediately

Approval marks the second drug approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs and signals FDA’s continued focus on facilitating development of new treatments to fight antimicrobial resistant infections

First collaboration product includes medical imaging capabilities to enable more personalized treatment decisions in cancer care

The cobas TV/MG test promises to provide the flexibility to process up to four sexually transmitted infections from one patient sample